Table 2.
Policy indicators, source, and year.
|
| ||
|---|---|---|
| INDICATOR | SOURCE | YEAR |
|
| ||
| National tobacco control programmes | WHO Global Health Observatory | 2018 |
|
| ||
| Policy/strategy/action plan for CVD | WHO Global Health Observatory | 2021 |
|
| ||
| Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs | WHO Global Health Observatory | 2021 |
|
| ||
| Guidelines/protocols/standards for the management of cardiovascular diseases | WHO Global Health Observatory | 2021 |
|
| ||
| Policy/strategy/action plan to reduce physical inactivity | WHO Global Health Observatory | 2021 |
|
| ||
| Policy/strategy/action plan to reduce unhealthy diet related to NCDs | WHO Global Health Observatory | 2021 |
|
| ||
| Policy/strategy/action plan to reduce the harmful use of alcohol | WHO Global Health Observatory | 2021 |
|
| ||
| Availability of ACE inhibitors, Aspirin (100 mg) and Beta blockers in the public health sector | WHO Global Health Observatory | 2021 |
|
| ||
Note: Availability of ACE inhibitors, Aspirin (100 mg) and Beta blockers in the public health sector is a combination of the three indicators 1) availability of ACE inhibitors in the public health sector; 2) availability of Aspirin (100 mg) in the public health sector; 3) availability of Beta blockers in the public health sector. If all 3 available the overall score was set to 1 if one or more not available the overall score was set to 0.